BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18441547)

  • 1. Fake drugs: lessons for the world. Dora Akunyili interviewed by Meredith Wadman.
    Akunyili D
    Nature; 2008 Apr; 452(7190):924. PubMed ID: 18441547
    [No Abstract]   [Full Text] [Related]  

  • 2. Counterfeit pharmaceuticals: in the line of fire. Dora Akunyili interviewed by Peter Aldhous.
    Akunyili D
    Nature; 2005 Mar; 434(7030):134. PubMed ID: 15758967
    [No Abstract]   [Full Text] [Related]  

  • 3. India agrees to help Nigeria tackle the import of fake drugs.
    Raufu A
    BMJ; 2003 Jun; 326(7401):1234. PubMed ID: 12791732
    [No Abstract]   [Full Text] [Related]  

  • 4. Dora Akunyili: battling against counterfeit drugs. Interview by Marilynn Larkin.
    Akunyili D
    Lancet Infect Dis; 2006 Sep; 6(9):554-5. PubMed ID: 16931405
    [No Abstract]   [Full Text] [Related]  

  • 5. Dora Akunyili: scourge of Nigerian drug counterfeiters.
    Harding A
    Lancet; 2006 May; 367(9521):1479. PubMed ID: 16679148
    [No Abstract]   [Full Text] [Related]  

  • 6. Counterfeit pharmaceuticals: murder by medicine.
    Aldhous P
    Nature; 2005 Mar; 434(7030):132-6. PubMed ID: 15758966
    [No Abstract]   [Full Text] [Related]  

  • 7. Deterring the importation of counterfeit pharmaceutical products.
    Stearn DW
    Food Drug Law J; 2004; 59(4):537-61. PubMed ID: 15875351
    [No Abstract]   [Full Text] [Related]  

  • 8. Beef up international cooperation on counterfeits.
    Shepherd M
    Nat Med; 2010 Apr; 16(4):366. PubMed ID: 20376036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fake penicillin, The Third Man, and Operation Claptrap.
    Newton PN; Timmermann B
    BMJ; 2016 Dec; 355():i6494. PubMed ID: 27965195
    [No Abstract]   [Full Text] [Related]  

  • 10. Counterfeit and substandard drugs in India may be smaller problem than claimed, say government findings.
    Travasso C
    BMJ; 2014 Jan; 348():g60. PubMed ID: 25489932
    [No Abstract]   [Full Text] [Related]  

  • 11. The "spurious drugs" gene and its pervasiveness.
    Srinivasan S
    Indian J Med Ethics; 2010; 7(3):136-9. PubMed ID: 20806518
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmaceutical expense, monitoring and scandals].
    Nicoletto SF
    Epidemiol Prev; 2004; 28(4-5):207-9. PubMed ID: 15732672
    [No Abstract]   [Full Text] [Related]  

  • 13. Bad medicine.
    Sheridan C
    Nat Biotechnol; 2007 Jul; 25(7):707-9. PubMed ID: 17621284
    [No Abstract]   [Full Text] [Related]  

  • 14. Expiry-date tampering.
    Day JN; Hien TT; Farrar J
    Lancet; 2004 Jan; 363(9403):172. PubMed ID: 14726189
    [No Abstract]   [Full Text] [Related]  

  • 15. Counterfeit drugs: implications for health.
    ten Ham M
    Adverse Drug React Toxicol Rev; 1992; 11(1):59-65. PubMed ID: 1606284
    [No Abstract]   [Full Text] [Related]  

  • 16. Killers on the loose.
    Nature; 2005 Mar; 434(7030):123. PubMed ID: 15758955
    [No Abstract]   [Full Text] [Related]  

  • 17. Health ministry institutes reward scheme for whistle-blowers reporting spurious drugs.
    Bhan A
    Natl Med J India; 2010; 23(1):56. PubMed ID: 20839601
    [No Abstract]   [Full Text] [Related]  

  • 18. Is the drugstore safe? Counterfeit diabetes products on the shelves.
    Cheng MM
    J Diabetes Sci Technol; 2009 Nov; 3(6):1516-20. PubMed ID: 20144408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fake drugs: a problem for all.
    McHugh A
    Br J Hosp Med (Lond); 2006 Oct; 67(10):551. PubMed ID: 17073011
    [No Abstract]   [Full Text] [Related]  

  • 20. Reinventing an industry.
    Mandavilli A
    Nature; 2007 Jan; 445(7124):138-9. PubMed ID: 17215817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.